Literature DB >> 1704551

Comparative evaluation of rate modulated dual chamber and VVIR pacing.

R V Jutzy1, J Florio, D M Isaeff, R J Marsa, R C Bansal, K R Jutzy, P A Levine, L Feenstra.   

Abstract

While dual chamber pacing is considered superior to VVI pacing at rest, there is a continuing debate as to the relative benefit of AV synchrony versus rate increase with exercise. To evaluate this question and to correlate different methods of evaluation, 14 patients with DDDR pacemakers were studied using serial treadmill exercise test with a CAEP protocol. Patients were exercised in DDD, DDDR, and VVIR modes. Echo-Doppler cardiac outputs were determined and pulmonary gas exchange was measured during exercise. There was a significant improvement in cardiac output with exercise in the DDDR versus VVIR modes, and in DDDR versus DDD modes in patients with chronotropic incompetence. There were small increases in exercise duration in DDDR versus VVIR modes, and small but consistent increases in VO2 at all levels of exercise, though not statistically significant. In this group of patients, DDDR pacing was superior to VVIR pacing, and superior to DDD pacing when chronotropic incompetence was present.

Entities:  

Mesh:

Year:  1990        PMID: 1704551     DOI: 10.1111/j.1540-8159.1990.tb06900.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Effect of rate-adaptive pacing on performance and physiological parameters during activities of daily living in the elderly: results from the CLEAR (Cylos Responds with Physiologic Rate Changes during Daily Activities) study.

Authors:  Freddy M Abi-Samra; Narendra Singh; Benjamin L Rosin; Jerome V Dwyer; Crystal D Miller
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

Review 2.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.